Loading…
Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair
Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for...
Saved in:
Published in: | Journal of vascular surgery 2012-09, Vol.56 (3), p.630-636 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903 |
---|---|
cites | cdi_FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903 |
container_end_page | 636 |
container_issue | 3 |
container_start_page | 630 |
container_title | Journal of vascular surgery |
container_volume | 56 |
creator | Abularrage, Christopher J., MD Patel, Virendra I., MD Conrad, Mark F., MD, MMSc Schneider, Eric B., PhD Cambria, Richard P., MD Kwolek, Christopher J., MD |
description | Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for PT2. Methods From 1999 to 2007, 136 patients who underwent endovascular aneurysm repair developed PT2 and comprised the study cohort. Primary end points included PT2 resolution (secondary interventional success) and survival, and were evaluated using multiple logistic regression and Kaplan-Meier analyses, respectively. Results Fifty-one patients underwent a total of 68 secondary interventions for PT2 with expanding aneurysm sacs with a median postsecondary interventional follow-up of 13.7 months. Secondary interventions included 20 inferior mesenteric artery coil embolizations, 17 Onyx glue embolizations, 11 aneurysm sac coil embolizations, 10 non-Onyx glue embolizations, 7 lumbar artery coil embolizations, 2 open lumbar ligations, and 1 graft explant. The overall secondary interventional success rate was 43% (29 of 68). Onyx glue embolization was associated with a greater success rate when used as the initial secondary intervention (odds ratio, 59.61; 95% confidence interval, 4.78-742.73; P < .001). There was no difference in success between the different techniques when multiple secondary interventions were required. Five-year survival was 72% ± 0.08% and was unrelated to any of the secondary interventional techniques. Conclusions Secondary intervention for PT2 is associated with success in less than half of all cases. Onyx glue embolization was associated with greater long-term success when used as the initial secondary intervention. |
doi_str_mv | 10.1016/j.jvs.2012.02.038 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1035107872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521412003874</els_id><sourcerecordid>1035107872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903</originalsourceid><addsrcrecordid>eNp9kk2LFDEQhoMo7rj6A7xILoKXHpN0upNGEGTxY2FhD-o5ZNKVNb39ZSo92P_etDMqeBAKQhXPW1V5KUKec7bnjNevu313xL1gXOxZjlI_IDvOGlXUmjUPyY4pyYtKcHlBniB2jHFeafWYXAhRKcFYsyN4PcxxOkJLI-DSJ6QLhvGO3o7rD3rXL0D9FGn6BjRFsGmAMdHJ0xkiBkxbltYZqKAwtlMP9p5anyD-So8W3dLbSO0IS1xxyDNmG-JT8sjbHuHZ-b0kXz-8_3L1qbi5_Xh99e6mcFLzVKiDBl2zA3dSwIHJStaVkl76srYeap1rnMmStdLVwLm23paVqGvvJFSsYeUleXXqm3_4fQFMZgjooO_zPtOChrOy4kxpJTLKT6iLE2IEb-YYBhvXDJnNa9OZ7LXZvDYsR6mz5sW5_XIYoP2j-G1uBl6egWyE7X20owv4l6tF0zSKZ-7NiYNsxjFANOgCjA7aEMEl007hv2u8_Uft-jCGPPAeVsBuWuKYXTbcYBaYz9tRbDfB846lVrL8CfCDslg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035107872</pqid></control><display><type>article</type><title>Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Abularrage, Christopher J., MD ; Patel, Virendra I., MD ; Conrad, Mark F., MD, MMSc ; Schneider, Eric B., PhD ; Cambria, Richard P., MD ; Kwolek, Christopher J., MD</creator><creatorcontrib>Abularrage, Christopher J., MD ; Patel, Virendra I., MD ; Conrad, Mark F., MD, MMSc ; Schneider, Eric B., PhD ; Cambria, Richard P., MD ; Kwolek, Christopher J., MD</creatorcontrib><description>Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for PT2. Methods From 1999 to 2007, 136 patients who underwent endovascular aneurysm repair developed PT2 and comprised the study cohort. Primary end points included PT2 resolution (secondary interventional success) and survival, and were evaluated using multiple logistic regression and Kaplan-Meier analyses, respectively. Results Fifty-one patients underwent a total of 68 secondary interventions for PT2 with expanding aneurysm sacs with a median postsecondary interventional follow-up of 13.7 months. Secondary interventions included 20 inferior mesenteric artery coil embolizations, 17 Onyx glue embolizations, 11 aneurysm sac coil embolizations, 10 non-Onyx glue embolizations, 7 lumbar artery coil embolizations, 2 open lumbar ligations, and 1 graft explant. The overall secondary interventional success rate was 43% (29 of 68). Onyx glue embolization was associated with a greater success rate when used as the initial secondary intervention (odds ratio, 59.61; 95% confidence interval, 4.78-742.73; P < .001). There was no difference in success between the different techniques when multiple secondary interventions were required. Five-year survival was 72% ± 0.08% and was unrelated to any of the secondary interventional techniques. Conclusions Secondary intervention for PT2 is associated with success in less than half of all cases. Onyx glue embolization was associated with greater long-term success when used as the initial secondary intervention.</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/j.jvs.2012.02.038</identifier><identifier>PMID: 22572009</identifier><identifier>CODEN: JVSUES</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Aged ; Aneurysm - mortality ; Aneurysm - surgery ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood Vessel Prosthesis Implantation - adverse effects ; Blood Vessel Prosthesis Implantation - mortality ; Boston ; Cardiology. Vascular system ; Chi-Square Distribution ; Dimethyl Sulfoxide - adverse effects ; Dimethyl Sulfoxide - therapeutic use ; Diseases of the aorta ; Drug Combinations ; Embolization, Therapeutic - adverse effects ; Embolization, Therapeutic - methods ; Embolization, Therapeutic - mortality ; Endoleak - diagnostic imaging ; Endoleak - etiology ; Endoleak - mortality ; Endoleak - therapy ; Endovascular Procedures - adverse effects ; Endovascular Procedures - mortality ; Female ; Humans ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Medical sciences ; Multivariate Analysis ; Odds Ratio ; Polyvinyls - adverse effects ; Polyvinyls - therapeutic use ; Proportional Hazards Models ; Reoperation ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Tantalum - adverse effects ; Tantalum - therapeutic use ; Time Factors ; Tomography, X-Ray Computed ; Treatment Outcome ; Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><ispartof>Journal of vascular surgery, 2012-09, Vol.56 (3), p.630-636</ispartof><rights>Society for Vascular Surgery</rights><rights>2012 Society for Vascular Surgery</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903</citedby><cites>FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26299971$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22572009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abularrage, Christopher J., MD</creatorcontrib><creatorcontrib>Patel, Virendra I., MD</creatorcontrib><creatorcontrib>Conrad, Mark F., MD, MMSc</creatorcontrib><creatorcontrib>Schneider, Eric B., PhD</creatorcontrib><creatorcontrib>Cambria, Richard P., MD</creatorcontrib><creatorcontrib>Kwolek, Christopher J., MD</creatorcontrib><title>Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for PT2. Methods From 1999 to 2007, 136 patients who underwent endovascular aneurysm repair developed PT2 and comprised the study cohort. Primary end points included PT2 resolution (secondary interventional success) and survival, and were evaluated using multiple logistic regression and Kaplan-Meier analyses, respectively. Results Fifty-one patients underwent a total of 68 secondary interventions for PT2 with expanding aneurysm sacs with a median postsecondary interventional follow-up of 13.7 months. Secondary interventions included 20 inferior mesenteric artery coil embolizations, 17 Onyx glue embolizations, 11 aneurysm sac coil embolizations, 10 non-Onyx glue embolizations, 7 lumbar artery coil embolizations, 2 open lumbar ligations, and 1 graft explant. The overall secondary interventional success rate was 43% (29 of 68). Onyx glue embolization was associated with a greater success rate when used as the initial secondary intervention (odds ratio, 59.61; 95% confidence interval, 4.78-742.73; P < .001). There was no difference in success between the different techniques when multiple secondary interventions were required. Five-year survival was 72% ± 0.08% and was unrelated to any of the secondary interventional techniques. Conclusions Secondary intervention for PT2 is associated with success in less than half of all cases. Onyx glue embolization was associated with greater long-term success when used as the initial secondary intervention.</description><subject>Aged</subject><subject>Aneurysm - mortality</subject><subject>Aneurysm - surgery</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Vessel Prosthesis Implantation - adverse effects</subject><subject>Blood Vessel Prosthesis Implantation - mortality</subject><subject>Boston</subject><subject>Cardiology. Vascular system</subject><subject>Chi-Square Distribution</subject><subject>Dimethyl Sulfoxide - adverse effects</subject><subject>Dimethyl Sulfoxide - therapeutic use</subject><subject>Diseases of the aorta</subject><subject>Drug Combinations</subject><subject>Embolization, Therapeutic - adverse effects</subject><subject>Embolization, Therapeutic - methods</subject><subject>Embolization, Therapeutic - mortality</subject><subject>Endoleak - diagnostic imaging</subject><subject>Endoleak - etiology</subject><subject>Endoleak - mortality</subject><subject>Endoleak - therapy</subject><subject>Endovascular Procedures - adverse effects</subject><subject>Endovascular Procedures - mortality</subject><subject>Female</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multivariate Analysis</subject><subject>Odds Ratio</subject><subject>Polyvinyls - adverse effects</subject><subject>Polyvinyls - therapeutic use</subject><subject>Proportional Hazards Models</subject><subject>Reoperation</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Tantalum - adverse effects</subject><subject>Tantalum - therapeutic use</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><subject>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kk2LFDEQhoMo7rj6A7xILoKXHpN0upNGEGTxY2FhD-o5ZNKVNb39ZSo92P_etDMqeBAKQhXPW1V5KUKec7bnjNevu313xL1gXOxZjlI_IDvOGlXUmjUPyY4pyYtKcHlBniB2jHFeafWYXAhRKcFYsyN4PcxxOkJLI-DSJ6QLhvGO3o7rD3rXL0D9FGn6BjRFsGmAMdHJ0xkiBkxbltYZqKAwtlMP9p5anyD-So8W3dLbSO0IS1xxyDNmG-JT8sjbHuHZ-b0kXz-8_3L1qbi5_Xh99e6mcFLzVKiDBl2zA3dSwIHJStaVkl76srYeap1rnMmStdLVwLm23paVqGvvJFSsYeUleXXqm3_4fQFMZgjooO_zPtOChrOy4kxpJTLKT6iLE2IEb-YYBhvXDJnNa9OZ7LXZvDYsR6mz5sW5_XIYoP2j-G1uBl6egWyE7X20owv4l6tF0zSKZ-7NiYNsxjFANOgCjA7aEMEl007hv2u8_Uft-jCGPPAeVsBuWuKYXTbcYBaYz9tRbDfB846lVrL8CfCDslg</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Abularrage, Christopher J., MD</creator><creator>Patel, Virendra I., MD</creator><creator>Conrad, Mark F., MD, MMSc</creator><creator>Schneider, Eric B., PhD</creator><creator>Cambria, Richard P., MD</creator><creator>Kwolek, Christopher J., MD</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120901</creationdate><title>Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair</title><author>Abularrage, Christopher J., MD ; Patel, Virendra I., MD ; Conrad, Mark F., MD, MMSc ; Schneider, Eric B., PhD ; Cambria, Richard P., MD ; Kwolek, Christopher J., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aneurysm - mortality</topic><topic>Aneurysm - surgery</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Vessel Prosthesis Implantation - adverse effects</topic><topic>Blood Vessel Prosthesis Implantation - mortality</topic><topic>Boston</topic><topic>Cardiology. Vascular system</topic><topic>Chi-Square Distribution</topic><topic>Dimethyl Sulfoxide - adverse effects</topic><topic>Dimethyl Sulfoxide - therapeutic use</topic><topic>Diseases of the aorta</topic><topic>Drug Combinations</topic><topic>Embolization, Therapeutic - adverse effects</topic><topic>Embolization, Therapeutic - methods</topic><topic>Embolization, Therapeutic - mortality</topic><topic>Endoleak - diagnostic imaging</topic><topic>Endoleak - etiology</topic><topic>Endoleak - mortality</topic><topic>Endoleak - therapy</topic><topic>Endovascular Procedures - adverse effects</topic><topic>Endovascular Procedures - mortality</topic><topic>Female</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multivariate Analysis</topic><topic>Odds Ratio</topic><topic>Polyvinyls - adverse effects</topic><topic>Polyvinyls - therapeutic use</topic><topic>Proportional Hazards Models</topic><topic>Reoperation</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Tantalum - adverse effects</topic><topic>Tantalum - therapeutic use</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><topic>Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abularrage, Christopher J., MD</creatorcontrib><creatorcontrib>Patel, Virendra I., MD</creatorcontrib><creatorcontrib>Conrad, Mark F., MD, MMSc</creatorcontrib><creatorcontrib>Schneider, Eric B., PhD</creatorcontrib><creatorcontrib>Cambria, Richard P., MD</creatorcontrib><creatorcontrib>Kwolek, Christopher J., MD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abularrage, Christopher J., MD</au><au>Patel, Virendra I., MD</au><au>Conrad, Mark F., MD, MMSc</au><au>Schneider, Eric B., PhD</au><au>Cambria, Richard P., MD</au><au>Kwolek, Christopher J., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>56</volume><issue>3</issue><spage>630</spage><epage>636</epage><pages>630-636</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><coden>JVSUES</coden><abstract>Objective Persistent type 2 (PT2) endoleaks (present ≥6 months) after endovascular aneurysm repair are associated with adverse outcomes, and selective secondary intervention is indicated in those patients with an expanding aneurysm sac. This study evaluated the outcomes of secondary intervention for PT2. Methods From 1999 to 2007, 136 patients who underwent endovascular aneurysm repair developed PT2 and comprised the study cohort. Primary end points included PT2 resolution (secondary interventional success) and survival, and were evaluated using multiple logistic regression and Kaplan-Meier analyses, respectively. Results Fifty-one patients underwent a total of 68 secondary interventions for PT2 with expanding aneurysm sacs with a median postsecondary interventional follow-up of 13.7 months. Secondary interventions included 20 inferior mesenteric artery coil embolizations, 17 Onyx glue embolizations, 11 aneurysm sac coil embolizations, 10 non-Onyx glue embolizations, 7 lumbar artery coil embolizations, 2 open lumbar ligations, and 1 graft explant. The overall secondary interventional success rate was 43% (29 of 68). Onyx glue embolization was associated with a greater success rate when used as the initial secondary intervention (odds ratio, 59.61; 95% confidence interval, 4.78-742.73; P < .001). There was no difference in success between the different techniques when multiple secondary interventions were required. Five-year survival was 72% ± 0.08% and was unrelated to any of the secondary interventional techniques. Conclusions Secondary intervention for PT2 is associated with success in less than half of all cases. Onyx glue embolization was associated with greater long-term success when used as the initial secondary intervention.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>22572009</pmid><doi>10.1016/j.jvs.2012.02.038</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0741-5214 |
ispartof | Journal of vascular surgery, 2012-09, Vol.56 (3), p.630-636 |
issn | 0741-5214 1097-6809 |
language | eng |
recordid | cdi_proquest_miscellaneous_1035107872 |
source | BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS |
subjects | Aged Aneurysm - mortality Aneurysm - surgery Biological and medical sciences Blood and lymphatic vessels Blood Vessel Prosthesis Implantation - adverse effects Blood Vessel Prosthesis Implantation - mortality Boston Cardiology. Vascular system Chi-Square Distribution Dimethyl Sulfoxide - adverse effects Dimethyl Sulfoxide - therapeutic use Diseases of the aorta Drug Combinations Embolization, Therapeutic - adverse effects Embolization, Therapeutic - methods Embolization, Therapeutic - mortality Endoleak - diagnostic imaging Endoleak - etiology Endoleak - mortality Endoleak - therapy Endovascular Procedures - adverse effects Endovascular Procedures - mortality Female Humans Kaplan-Meier Estimate Logistic Models Male Medical sciences Multivariate Analysis Odds Ratio Polyvinyls - adverse effects Polyvinyls - therapeutic use Proportional Hazards Models Reoperation Retrospective Studies Risk Assessment Risk Factors Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tantalum - adverse effects Tantalum - therapeutic use Time Factors Tomography, X-Ray Computed Treatment Outcome Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels |
title | Improved results using Onyx glue for the treatment of persistent type 2 endoleak after endovascular aneurysm repair |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A58%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improved%20results%20using%20Onyx%20glue%20for%20the%20treatment%20of%20persistent%20type%202%20endoleak%20after%20endovascular%20aneurysm%20repair&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Abularrage,%20Christopher%20J.,%20MD&rft.date=2012-09-01&rft.volume=56&rft.issue=3&rft.spage=630&rft.epage=636&rft.pages=630-636&rft.issn=0741-5214&rft.eissn=1097-6809&rft.coden=JVSUES&rft_id=info:doi/10.1016/j.jvs.2012.02.038&rft_dat=%3Cproquest_cross%3E1035107872%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c481t-7b8e860b1c42eb04546574f4f36afe68eb010430d4c6e118afa35266fc4e50903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1035107872&rft_id=info:pmid/22572009&rfr_iscdi=true |